Opinion 14 Mar 2022
The Secrets to 50 Years of Success in Life Sciences Investment
The European life sciences venture capital firm Sofinnova Partners is celebrating its 50th birthday this year. Sofinnova’s Chairman and Managing…
About
Antoine Papiernik is a Managing Partner at the life sciences VC firm Sofinnova Partners. He has been an initial investor and active board member in Actelion, ProQR, NovusPharma, Movetis, Mainstay, Pixium Vision and Stentys, among others.
Articles by Antoine Papiernik
Opinion 7 Jul 2021
Three Lessons an Investor Can Learn from Biotech Entrepreneurs
Sofinnova Partners’ Chairman and Managing Partner, Antoine Papiernik, describes his company’s ‘Wall of Fame’ showcasing its entrepreneurs and how their…
Opinion 8 Mar 2021
Advice for my Younger Self: How to Be a VC in Life Sciences
Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, looks back at where he was two decades ago and shares…
Opinion 30 Sep 2019
Can European Biotech Companies Afford Not to Work with China?
In the current trade standoff between the US and China, Europe has a golden opportunity to gain a competitive advantage.…
ADVERTISEMENT
Opinion 16 Jul 2019
The Business of Biotech: What to Do When the S*#t Hits the Fan
From CEO-itis to FDA-itis, the path of a biotech company is never dull. Whether the oft-repeated saying, “may you live…
Opinion 5 Jun 2019
Is Going Public in Europe the Kiss of Death?
The key for a European biotech is to find the money where it is. And that’s not in Europe for…